“Antigma-Screen” Reagent Kit for Enzyme Immunoassay Detection of Total Antibodies to SARS-CoV-2 Virus (TU 21.20.23-072-26329720-2020, Batch С110520)

The “Antigma-Screen” kit is designed for the enzyme-linked immunosorbent assay (ELISA) detection of total antibodies to the SARS-CoV-2 virus.

Technical Specifications: TU 21.20.23-072-26329720-2020
Batch: С110520
Configuration: Set 3, for 96 determinations

Kit Components:

Immunosorbent – 1 unit
K+ – Positive control sample, inactivated – 1 vial (1.5 mL)
K− – Negative control sample, inactivated – 1 vial (3.0 mL)
RBR-C – Serum dilution buffer – 1 vial (12.0 mL)
Kr – Conjugate – 1 vial (1.5 mL)
RBR-K – Conjugate dilution buffer – 1 vial (13.0 mL)
BRS – Substrate buffer solution – 1 vial (13.0 mL)
TMB – Tetramethylbenzidine – 1 vial (1.0 mL)
FSB-T(x25) – 25x concentrate of phosphate-buffered saline with Tween – 1 vial (28.0 mL)
Stop Reagent – 0.9 mol/L sulfuric acid solution – 1 vial (6.0 mL)

Accessories:

Protective film for microplates – 2 pcs
Reagent trays – 2 pcs
Disposable polymer pipette tips (0.5–250 µL) – 16 pcs

Documentation:

User manual with appendix – 1 copy

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, “Antigma-Screen” Reagent Kit for Enzyme Immunoassay Detection of Total Antibodies to SARS-CoV-2 Virus (TU 21.20.23-072-26329720-2020, Batch С110520), then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back